The weekly litigation news digest is live. Subscribe now

IP Verse

Inhibition Of Crystal Growth Of Roflumilast - EP3634380

The patent EP3634380 was granted to Arcutis on Jan 10, 2024. The application was filed on Jun 4, 2018 under application number EP18733481A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3634380

ARCUTIS
Application Number
EP18733481A
Filing Date
Jun 4, 2018
Status
Granted And Under Opposition
Dec 8, 2023
Publication Date
Jan 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSSep 20, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP1511516
DESCRIPTIONUS5712298
DESCRIPTIONUS5863560
DESCRIPTIONUS9205044
DESCRIPTIONWO9501338
INTERNATIONAL-SEARCH-REPORTWO2013081565
INTERNATIONAL-SEARCH-REPORTWO2014055801
OPPOSITIONUS2007259009
OPPOSITIONWO03099334
OPPOSITIONWO2013081565
OPPOSITIONWO2014055801

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents